Trial Profile
Efficacy of Teneligliptin in patients with diabetes with chronic kidney disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Jun 2017
Price :
$35
*
At a glance
- Drugs Teneligliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics; Therapeutic Use
- 13 Jun 2017 New trial record
- 02 Jun 2017 Results published in the Drugs in R and D